Literature DB >> 21147937

Hsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo.

Kerry McLaughlin1, Veronica B Carr, Munir Iqbal, Julian Seago, Eric A Lefevre, Lucy Robinson, Helen Prentice, Bryan Charleston.   

Abstract

The use of heat shock proteins (HSP) to enhance activation of the immune response to chaperoned antigen is being explored for immunotherapy. Hsp110 chaperones large protein substrates more effectively than Hsp70, offering the potential to use complex antigens containing multiple epitopes in HSP-based vaccines. In this study, we investigated the ability of recombinant bovine Hsp110 to chaperone E2 glycoprotein, the major envelope protein of bovine viral diarrhea virus (BVDV) and the dominant target of neutralizing antibodies. Hsp110 formed complexes with E2, as demonstrated by immunoprecipitation. When monocytes from BVDV-immunized cattle were stimulated with these complexes and incubated with autologous CD4(+) T cells, enhanced levels of proliferation were observed. To determine the ability of these complexes to improve immunogenicity in vivo, cattle were vaccinated with either Hsp110-E2 complex or E2 only, combined with Quil-A adjuvant. In contrast to the in vitro data, cellular and humoral responses to E2 were greater in the E2-only vaccination group, indicating that complex formation had actually reduced the immunogenicity of E2. This study highlights the need for further understanding of the means by which HSP complexes are endocytosed and processed in vivo to enable the design of successful vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147937      PMCID: PMC3067363          DOI: 10.1128/CVI.00414-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

Review 1.  Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

Authors:  Pramod Srivastava
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Improving baculovirus recombination.

Authors:  Yuguang Zhao; David A G Chapman; Ian M Jones
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

3.  Heat shock proteins as regulators of the immune response.

Authors:  A Graham Pockley
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

4.  Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages.

Authors:  Baochong Gao; Min-Fu Tsan
Journal:  J Biol Chem       Date:  2002-10-27       Impact factor: 5.157

5.  Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.

Authors:  Masoud H Manjili; Robert Henderson; Xiang-Yang Wang; Xing Chen; Ying Li; Elizabeth Repasky; Latif Kazim; John R Subjeck
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

6.  A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue.

Authors:  U Wendling; L Paul; R van der Zee; B Prakken; M Singh; W van Eden
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  Development of an ELISA for bovine IL-10.

Authors:  L S Kwong; J C Hope; M L Thom; P Sopp; S Duggan; G P Bembridge; C J Howard
Journal:  Vet Immunol Immunopathol       Date:  2002-03       Impact factor: 2.046

Review 8.  Immunotherapy of cancer using heat shock proteins.

Authors:  Masoud H Manjili; Xiang-Yang Wang; Juneui Park; John G Facciponte; Elizabeth A Repasky; John R Subjeck
Journal:  Front Biosci       Date:  2002-01-01

9.  Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response induction.

Authors:  Gillian Martínez-Donato; Alexis Musacchio; Liz Alvarez-Lajonchere; Nelson Acosta-Rivero; Yalena Amador; Ivis Guerra; Dilver Peña; Angel Pérez; Jorge Castro; Pedro Puentes; Yordanka Soria; Karelia Cosme; Jorge Sanchez; Santiago Dueñas-Carrera
Journal:  Biotechnol Appl Biochem       Date:  2010-07-09       Impact factor: 2.431

10.  Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.

Authors:  Xiang-Yang Wang; Xing Chen; Masoud H Manjili; Elizabeth Repasky; Robert Henderson; John R Subjeck
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

View more
  2 in total

Review 1.  Diversity in heat shock protein families: functional implications in virus infection with a comprehensive insight of their role in the HIV-1 life cycle.

Authors:  Kruthika Iyer; Kailash Chand; Alapani Mitra; Jay Trivedi; Debashis Mitra
Journal:  Cell Stress Chaperones       Date:  2021-07-27       Impact factor: 3.667

Review 2.  Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications.

Authors:  Daming Zuo; John Subjeck; Xiang-Yang Wang
Journal:  Front Immunol       Date:  2016-03-01       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.